Skip to content
PubMed This is a summary of 76 peer-reviewed journal articles Updated
Oncology

Primary Cutaneous T-Cell Lymphoma (CTCL) Resource Guide

At a Glance

Primary Cutaneous T-Cell Lymphoma (CTCL) is a rare, slow-growing lymphoma that primarily affects the skin, often mimicking eczema. It is typically managed as a chronic condition using a combination of skin-directed therapies and systemic care overseen by both dermatologists and oncologists.

Hearing the word “lymphoma” can be overwhelming, especially when it is used to describe a rash you may have been treating as eczema for years. Primary Cutaneous T-Cell Lymphoma (CTCL) is a rare condition that sits at the intersection of dermatology and oncology. It behaves very differently from traditional internal lymphomas, and for most people, it is a slow-growing (indolent) condition that is managed as a chronic disease.

This guide was built specifically for you. It translates the complexities of this rare diagnosis into actionable, clear information so that you can navigate your care with confidence. Whether you are still questioning your pathology report, dealing with severe itching, or trying to assemble the right doctors, these pages will guide you on what to ask and what to expect.

Guide Contents

Common questions in this guide

What is Primary Cutaneous T-Cell Lymphoma (CTCL)?
CTCL is a rare type of non-Hodgkin lymphoma that primarily affects the skin. Unlike traditional internal lymphomas, it is typically a slow-growing condition that is managed as a chronic disease rather than an acute emergency.
Why does CTCL often take a long time to diagnose?
CTCL is often called the "great mimicker" because its early symptoms, such as chronic rashes and severe itching, closely resemble common skin conditions like eczema or psoriasis. This frequently leads to significant diagnostic delays before a specialized biopsy confirms the disease.
What kind of doctors should I see for CTCL?
Because CTCL sits at the intersection of dermatology and oncology, it is best to be evaluated at a multidisciplinary cutaneous lymphoma center. Your primary care team will typically include both dermatologists and medical oncologists who specialize in skin lymphomas.
How will my doctor determine the stage of my CTCL?
Your exact stage and subtype are determined using the TNMB staging system, which looks at tumors, nodes, metastasis, and blood involvement. Knowing the difference between common subtypes like Mycosis Fungoides and Sézary Syndrome is critical for determining your treatment plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If my initial diagnosis was just made, how will we determine the full extent (stage) of my CTCL?
  2. 2.Do I need a referral to a multidisciplinary cutaneous lymphoma center?
  3. 3.Are there specific daily habits or skin care routines I should start immediately while we wait for staging results?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide provides an educational overview of Primary Cutaneous T-Cell Lymphoma (CTCL). It is for informational purposes only and does not replace professional medical advice. Always consult your dermatologist or oncologist regarding your specific diagnosis and treatment.

Get notified when new evidence is published on Primary cutaneous T-cell lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.